Dr. Günter Höglinger
Dr. Günter Höglinger is the Director of the Dept. of Neurology at Hannover Medical University since June 2019, and President of the German Parkinson Society since March 2019. Before that, he held the Chair for Translational Neurodegeneration at the German Center for Neurodegenerative Diseases (DNZE), Munich, and the Technical University of Munich (TUM). Dr. Höglinger was also a Senior Consultant at the Department of Neurology at TUM and heads the Interdisciplinary Clinical Trial Unit at the DZNE Munich.
After completing a Vor-Diplom (equivalent to BSc) in Physics at the University of Regensburg, Germany, Dr. Höglinger received his MD at the universities of Würzburg and Marburg, Germany in 2000. From 2000 to 2003, he completed a post-doctoral fellowship at the Hôpital Pitié Salpêtrière in Paris. From 2003 to 2007 he completed a clinical neurological training at the University of Marburg.
Dr. Höglinger’s area of investigation focuses on akinetic-rigid Parkinson syndromes. His main research interests include determining genetic and environmental risk factors for neurodegenerative disease, molecular mechanisms of neurodegeneration, modern imaging aiming at the identification of disease mechanisms, and improving diagnostic tools in order to develop novel therapeutics.
As an active member of the scientific community, Dr. Höglinger is Chair of the International Movement Disorders Society-endorsed PSP Study Group and member of the Scientific Advisory Boards of AbbVie, Asceneuron, Biogen, Sanofi, and UCB. He is currently President-elect of the German Parkinson Association.
In 2017, Dr. Höglinger was a recipient of the Dingebauer Prize from the German Society for Neurology (DGN) for his research in Parkinson Syndromes. He was also a recipient of a Professorship in the Heisenberg excellence program of the German Research Foundation (DFG) (2011-2016), and a First Prize winner for ‘Innovative strategies for neurodegenerative disorders’ from the Dr. Walter and Louise Freundlich Foundation.